ArticleMolecular biotechnology2026
Biogenic Nickel Oxide Nanoparticles: Synthesis, Characterization and Biomedical Potential.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine learning-based fabrication of phytogenic NiO nanoparticles for anticancer activity in HepG2 Cell Culture.Journal of materials science. Materials in medicine · 2025Article
- Bismuth nickelate nanoparticles synthesized using Curcuma longa rhizome extract as biocidal and photocatalytic agents.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green-synthesized nanoparticles provide an eco-friendly approach to nanotechnology, reducing harmful chemical use and environmental impact. This study focuses on the green synthesis of nickel oxide nanoparticles (FV-NiO NPs) using Fioria vitifolia. Synthesized NPs were characterization by UV, XRD, FTIR, SEM, and TEM revealed spherical, well-dispersed particles (17-168 nm) with a UV-Visible absorption peak at 247 nm. EDAX analysis confirmed their composition: 55.02% Ni, 22.77% O, 18.49% C, and 3.71% Na. FV-NiO NPs exhibited potent antibacterial activity at 100 µg/mL against Escherichia coli (21.1 ± 0.2 mm inhibition) and Enterococcus faecalis (24.6 ± 0.5 mm inhibition). Furthermore, anti-inflammatory activity showed 68.3% inhibition at 200 µg/mL, while antioxidant assays demonstrated 78.64% DPPH and 68.21% ABTS inhibition at 100 µg/mL. Antitumour assays revealed an IC
Indexed as
Identifiers
40042765What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.